European Pharmaceutical Review

JULY 21, 2023

Manufacturing delays and capacity issues that continue to impact the pharmaceutical supply chain have led to medicine shortages around the globe; an issue that has been exacerbated further by geopolitical events, the energy crisis and rising inflation. What are the top three supply-related challenges facing pharmaceutical manufacturers?

Pharmaceutical 93

Pharmaceutical Food and Drug Administration Transportation Manufacturing 93

European Pharmaceutical Review

MARCH 12, 2024

In the pharmaceutical/life sciences industries, maintaining data integrity is crucial given its role in making critical decisions that shape outcomes from drug development to human health. Blockchain technology creates a decentralised and unalterable ledger that records all transactions across a network of computers.

Government 86

Government Pharma Ethics Training 86

European Pharmaceutical Review

APRIL 21, 2023

In addition, the number of active substances detected in the environment has been increasing with unknown consequences for ecosystems and the accumulation of substances in food chains. Giving environmental risk assessments teeth Since 2005, the authorisation of a human pharmaceutical product requires an environmental risk assessment (ERA).

Pharma 79

Pharma Food and Drug Administration Medicine Pharmaceutical 79

European Pharmaceutical Review

JANUARY 16, 2023

This also occupies a large resource, given the US Food and Drug Administration (FDA) requirement for double plate checking using a second ‘independent’ person. Tony Cundell: Perhaps the second greatest challenge is the ongoing transition from products based on small molecules to large molecules to cellular therapies.

Pharmaceutical 125

Pharmaceutical Food and Drug Administration Manufacturing FDA 125

Cadensee

JULY 20, 2021

40:28 Are there any social networking tools that can be used to differentiate B2B from B2C. 43:32 What is the National Advisory Board for digital health for the Ministry of Health in and what are Uri's goals in the advisory board? It might be silly question but bringing a drug to market takes many, many years.

Food and Drug Administration 52

Food and Drug Administration Doctors Healthcare Healthcare 52